1. Disease and Biological Landscape

Every strategy begins with understanding the biology of the disease.

This section of the Strategy Map consolidates the patient’s diagnosis, pathology findings, and biomarker information into a clear scientific profile. The goal is to clarify how the tumor behaves biologically and how those features influence treatment approaches.

Patients receive a structured overview of:

• tumor type and histology
• stage and disease distribution
• pathology findings
• molecular and biomarker results
• biological drivers relevant to the disease

Understanding the biological landscape provides the foundation for interpreting current and future treatment options.

2. Current Treatment Position

The Strategy Map then places the patient’s current therapy into the broader context of cancer treatment sequencing.

This section explains how the current treatment works, why it is commonly used at this stage of disease, and how physicians typically evaluate response.

Patients receive insight into:

• the mechanism and purpose of the current therapy
• expected patterns of response
• how treatment effectiveness is monitored
• imaging and assessment milestones that guide decision making

This helps patients understand where they are within the treatment pathway and what physicians are watching for as therapy progresses.

3. Future Treatment and Clinical Pathways

Cancer care often involves multiple potential treatment directions over time. Understanding those possibilities early can help patients prepare for future decisions.

This section of the Strategy Map reviews the broader therapeutic landscape and highlights areas of ongoing research.

Patients receive an overview of:

• potential treatment pathways that may arise later in care
• emerging therapeutic approaches under investigation
• clinical trial opportunities relevant to the disease type

4. Strategic Inflection Points and Decision Planning

The final component of the Strategy Map focuses on identifying the moments in care when reassessment becomes most important.

Cancer treatment frequently involves points where new information changes the strategic landscape. These moments may include treatment response evaluations, disease progression, or opportunities to explore clinical trials.

This section highlights:

• key inflection points in the treatment journey
• when reassessment may be valuable
• when second opinions may be appropriate
• when to explore clinical trial options
• questions patients may wish to discuss with their oncologist

By anticipating these decision points, patients can approach their care more proactively and engage in more informed conversations with their medical team.

Strategy Consultation and Report Review

Following completion of the Oncology Strategy Map™, clients participate in a private consultation session to review the report in detail.

During this discussion, we walk through each component of the Strategy Map together, translating the scientific and clinical information into clear explanations that patients and families can understand. The goal of this conversation is to ensure that clients fully understand the biological context of their disease, how their current treatment fits within the broader oncology landscape, and what future developments may influence care decisions.

During the consultation we review:

• the biological characteristics of the tumor and what they may mean for treatment
• how the current therapy works and how physicians typically evaluate response
• the broader treatment and research landscape relevant to the disease
• potential clinical trial pathways and eligibility considerations
• upcoming decision points that may shape the next phase of care

The consultation also provides an opportunity for patients and families to ask questions and clarify aspects of their diagnosis or treatment that may not have been fully explained during clinical visits.

Many clients find that this discussion helps them translate complex oncology science into practical insights they can bring into conversations with their treating physicians.

By the end of the session, patients typically leave with:

• a clearer understanding of their disease biology
• greater confidence in discussing treatment strategy with their oncologist
• awareness of potential future treatment and trial pathways
• a framework for navigating key decision points in their care

The goal of the consultation is not to direct treatment decisions, but to help patients approach their oncology visits with greater preparation, clarity, and understanding.